jili super ace mod apk
Charles Schwab Investment Management Inc. raised its position in Trex Company, Inc. ( NYSE:TREX – Free Report ) by 3.2% in the 3rd quarter, Holdings Channel reports. The firm owned 902,070 shares of the construction company’s stock after buying an additional 27,992 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Trex were worth $60,060,000 at the end of the most recent reporting period. A number of other hedge funds have also recently made changes to their positions in TREX. Hantz Financial Services Inc. purchased a new position in shares of Trex during the second quarter worth about $31,000. UMB Bank n.a. grew its stake in Trex by 150.8% in the 3rd quarter. UMB Bank n.a. now owns 652 shares of the construction company’s stock worth $43,000 after buying an additional 392 shares in the last quarter. Ashton Thomas Private Wealth LLC purchased a new position in Trex in the 2nd quarter worth approximately $44,000. Quarry LP raised its position in shares of Trex by 576.4% during the 2nd quarter. Quarry LP now owns 602 shares of the construction company’s stock valued at $45,000 after buying an additional 513 shares in the last quarter. Finally, Mather Group LLC. lifted its holdings in shares of Trex by 142.3% during the 2nd quarter. Mather Group LLC. now owns 630 shares of the construction company’s stock worth $47,000 after acquiring an additional 370 shares during the last quarter. 95.96% of the stock is currently owned by hedge funds and other institutional investors. Analyst Ratings Changes A number of research analysts recently commented on the company. StockNews.com cut Trex from a “hold” rating to a “sell” rating in a research note on Tuesday, October 29th. Robert W. Baird increased their price objective on Trex from $70.00 to $78.00 and gave the company a “neutral” rating in a research report on Tuesday, October 29th. Truist Financial dropped their target price on Trex from $120.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. BMO Capital Markets increased their price target on shares of Trex from $67.00 to $72.00 and gave the company a “market perform” rating in a research report on Tuesday, October 29th. Finally, B. Riley lowered their price objective on shares of Trex from $107.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $79.94. Trex Trading Up 0.8 % TREX stock opened at $75.03 on Friday. The firm’s 50-day moving average price is $68.49 and its two-hundred day moving average price is $73.00. The stock has a market capitalization of $8.04 billion, a price-to-earnings ratio of 34.26, a PEG ratio of 3.39 and a beta of 1.49. Trex Company, Inc. has a 12-month low of $58.68 and a 12-month high of $101.91. Trex ( NYSE:TREX – Get Free Report ) last announced its quarterly earnings results on Monday, October 28th. The construction company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.32 by $0.05. Trex had a return on equity of 28.89% and a net margin of 20.23%. The company had revenue of $233.72 million for the quarter, compared to the consensus estimate of $225.42 million. During the same quarter in the previous year, the business earned $0.57 EPS. Trex’s revenue was down 23.1% compared to the same quarter last year. Equities analysts predict that Trex Company, Inc. will post 2.05 EPS for the current year. Trex Company Profile ( Free Report ) Trex Company, Inc manufactures and distributes composite decking, railing, and outdoor living products and accessories for residential and commercial markets in the United States. It offers decking products and accessories under the names Trex Transcend, Trex Select, Trex Signature, Trex Transcend Lineage, and Trex Enhance for protection against fading, staining, mold, and scratching; Trex Hideaway, a hidden fastening system; and Trex DeckLighting, a LED dimmable deck lighting for use on posts, floors, and steps. Recommended Stories Want to see what other hedge funds are holding TREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trex Company, Inc. ( NYSE:TREX – Free Report ). Receive News & Ratings for Trex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trex and related companies with MarketBeat.com's FREE daily email newsletter .
Global Travel and Expense T amp E Software Market Size, Share and Forecast By Key Players-Oracle Corporation, Apptricity Corp., SAP SE (Concur), Basware, Expensify
SAN DIEGO , Dec. 5, 2024 /PRNewswire/ -- Sempra (NYSE: SRE) (BMV: SRE) today announced it has been recognized by Newsweek as one of "America's Most Responsible Companies" for 2025, earning this distinction for the sixth consecutive year. The annual list ranks companies based on their commitment to corporate responsibility in the areas of corporate governance and responsible social and environmental practices. Sempra has been included since the list's inception. "At Sempra, we believe our responsible business practices improve the value of our franchise. By strengthening governance and risk management and improving the safety and resiliency of our business operations, it allows us to better meet the needs and expectations of our customers, while also adding scale to our business," said Lisa Larroque Alexander , senior vice president of corporate affairs and chief sustainability officer for Sempra. "We will continue to approach global energy challenges with an entrepreneurial mindset, steadfast optimism and confidence in our vision of delivering energy with purpose." Newsweek's recognition of Sempra as one of "America's Most Responsible Companies" is based on publicly available key performance indicators derived from the company's Corporate Sustainability Report and an independent survey that asked U.S. citizens about their perception of Sempra's commitment to corporate social responsibility. Details of Sempra's approach to responsible stakeholder engagement and corporate governance can be found in the company's most recent Corporate Sustainability Report, which is available here . In addition to being recognized on Newsweek's America's Most Responsible Companies list, Sempra is included in the FTSE4Good Index and JUST 100 list, has been named one of TIME Magazine's World's Best Companies and one of Fortune Magazine's World's Most Admired Companies , and earned a perfect score on the CPA-Zicklin Index of Corporate Political Disclosure and Accountability , among other accolades. About Sempra Sempra (NYSE: SRE ) is a leading North American energy infrastructure company focused on delivering energy to nearly 40 million consumers. As owner of one of the largest energy networks on the continent, Sempra is electrifying and improving the energy resilience of some of the world's most significant economic markets, including California , Texas , Mexico and global energy markets. The company is recognized as a leader in sustainable business practices and for its high-performance culture focused on safety and operational excellence, as demonstrated by Sempra's inclusion in the Dow Jones Sustainability Index North America and in The Wall Street Journal's Best Managed Companies. More information about Sempra is available at sempra.com and on social media @Sempra . View original content to download multimedia: https://www.prnewswire.com/news-releases/sempra-named-among-newsweeks-most-responsible-companies-302324298.html SOURCE SempraKolkata, Dec 15 (PTI) IT industry veteran and Infosys founder NR Narayana Murthy on Sunday emphasised the need for using advanced technologies, including Artificial intelligence (AI), in India, stating that technology is a “great leveller”. Technology can help reduce the gap between the well-to-do and the not-so-well people, Murthy said while speaking at the centenary celebration of the Indian Chamber of Commerce here. “Technology is about reducing cost. It’s about increasing revenues and profitability. So technology has a lot of value. It also does something that most people don’t realise. Technology is a great leveller. So we need technology in India if we want to reduce the gap between the well-to-do and the not-so-well. That’s what financial inclusion has done,” he said. “My personal view is there are areas where we cannot do without AI,” Murthy said. He said AI can be used in areas like automatic cars, precision operations, disease detection and hazardous operations in which human beings may be exposed to high risk. Murthy stressed the need for hard work and performance to earn respect for oneself and for the country. “I urge the youngsters to understand that we have a great responsibility to fulfil the pledge of our founding fathers (of the nation). We have greater responsibility as enunciated by scriptures. We have to show fairness and justice to create opportunities for the less fortunate one. That is why we have to work hard,” he said. Murthy also asked entrepreneurs to embrace “compassionate capitalism” which is practising capitalism while combining it with the best aspect of liberalism and the best aspect of socialism. PTI BDC NN This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content. var ytflag = 0;var myListener = function() {document.removeEventListener('mousemove', myListener, false);lazyloadmyframes();};document.addEventListener('mousemove', myListener, false);window.addEventListener('scroll', function() {if (ytflag == 0) {lazyloadmyframes();ytflag = 1;}});function lazyloadmyframes() {var ytv = document.getElementsByClassName("klazyiframe");for (var i = 0; i < ytv.length; i++) {ytv[i].src = ytv[i].getAttribute('data-src');}} Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );
AP News Summary at 11:51 a.m. EST
None10 Greatest Goalkeepers in Manchester United History [Ranked]
Outbrain Shareholders Vote to Support Teads AcquisitionJimmy Carter, 39th US president, Nobel winner, dies at 100
CORK, Ireland , Dec. 5, 2024 /PRNewswire/ -- The board of directors of Johnson Controls International plc (NYSE: JCI), the global leader in smart, healthy and sustainable buildings, has approved a regular quarterly dividend of $0.37 per share of common stock, payable on Jan. 17, 2025 , to shareholders of record at the close of business on Dec. 23, 2024 . Johnson Controls has paid a consecutive dividend since 1887. About Johnson Controls At Johnson Controls (NYSE:JCI), we transform the environments where people live, work, learn and play. As the global leader in smart, healthy and sustainable buildings, our mission is to reimagine the performance of buildings to serve people, places and the planet. Building on a proud history of nearly 140 years of innovation, we deliver the blueprint of the future for industries such as healthcare, schools, data centers, airports, stadiums, manufacturing and beyond through OpenBlue, our comprehensive digital offering. Today, with a global team of experts, Johnson Controls offers the world`s largest portfolio of building technology and software as well as service solutions from some of the most trusted names in the industry. Visit www.johnsoncontrols.com for more information and follow @Johnson Controls on social platforms. INVESTOR CONTACT: Jim Lucas Direct: +1 414.340.1752 Email: jim.lucas@jci.com MEDIA CONTACT: Danielle Canzanella Direct: +1 203.499.8297 Email: danielle.canzanella@jci.com View original content to download multimedia: https://www.prnewswire.com/news-releases/johnson-controls-announces-quarterly-dividend-302324312.html SOURCE Johnson Controls International plc
Ottawa tow truck companies, driver charged after complaints made to policeNone
Genetic Testing Market Growth Outlook by 2031 Bio-Rad Laboratories, F. Hoffmann-La Roche, Myriad Genetics, QIAGEN, Quest Diagnostics 12-05-2024 09:36 PM CET | Health & Medicine Press release from: STATS N DATA Genetic Testing Market [New York, December 2024] Genetic Testing represents a radical shift in healthcare, leveraging cutting-edge technology to analyze an individual's DNA to evaluate risk factors, potential diseases, and inheritance patterns. Often hailed as a cornerstone of personalized medicine, genetic testing plays a pivotal role in diagnosing genetic disorders, guiding treatment decisions, and enhancing preventive healthcare strategies. As healthcare continues to evolve, the relevance of genetic testing is indisputable, transforming not only the medical landscape but also the biotechnology and pharmaceutical sectors. The application of genetic insights is opening new avenues for research and development, underlining the significance of this market for industry players and investors alike. You can access a sample PDF report here: https://www.statsndata.org/download-sample.php?id=38369 The Genetic Testing market is poised for remarkable growth in the coming years, driven by technological advancements and increasing public awareness of genetic health. Stakeholders already engaged in this sector can reap significant rewards as demand escalates for innovative testing solutions and services. This landscape is becoming an attractive field for new entrants, who can capitalize on rising consumer interest in personalized healthcare options. As organizations scramble to offer advanced genetic testing services to meet growing market demand, the shift toward preventive health management opens doors for investment and innovation that can reshape the industry.Looking back, the Genetic Testing market has evolved dramatically, marked by significant technological advancements and a growing acceptance of genetic insights in mainstream medicine. Early trends focused primarily on rare genetic disorders, while current developments encompass a broad spectrum, including prenatal testing and cancer genomics. Although the genetic testing field faces certain challenges, such as ethical concerns and regulatory hurdles, major players have successfully navigated these issues, securing strong positions in this lucrative market. As the future unfolds, the potential for innovation appears boundless. For those considering entering the Genetic Testing market, now is the time to invest in this transformative sector that promises not only financial returns but also the chance to contribute to life-saving medical advancements.In an ever-changing business world, staying informed of market trends is vital for maintaining a competitive edge. STATS N DATA's Global Genetic Testing Market Report offers an essential look at the current market dynamics and future potential. Covering 2024 to 2031, this report delivers expert analysis and forecasts that empower businesses and investors to make smart, data-backed decisions to strengthen their market positions. As a valuable resource, this report presents a clear view of today's market conditions and the major factors that will drive future growth. With insights from top industry experts, it helps companies plan around upcoming trends and sharpen their competitive edge. The Global Genetic Testing Market has shown steady growth, driven by technological advances and rising demand across industries. STATS N DATA's report investigates this growth and delves into the factors that are powering it forward. Key Drivers and Challenges The report pinpoints essential growth drivers like new technology and changing consumer demands while also identifying challenges, such as regulatory changes and economic pressures. This dual perspective supports businesses in developing strategies that maximize opportunities and effectively address potential risks, securing long-term success. Comprehensive Market Segmentation To provide clear insights, the Global Genetic Testing Market is segmented into key categories: Market Segmentation: By Type • Predictive and Diagnostic Testing • Prenatal, Newborn, and Pre-Implantation Testing • Pharmacogenomic Testing • Forensic, Relationship, and Ancestry Testing Market Segmentation: By Application • Analyzers • Consumables Get 30% Discount On Full Report: https://www.statsndata.org/ask-for-discount.php?id=38369 Each segment is analyzed to highlight market size, growth potential, and trends. This segmentation helps companies identify high-growth areas and efficiently allocate resources. An attractiveness analysis also evaluates each segment's potential, considering competition and opportunities in the market. Regional Analysis and Global Perspective The report offers a full regional analysis of the Global Genetic Testing Market, covering North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. This breakdown is ideal for businesses looking to expand or adapt their strategies to fit specific regions, with high-growth regions spotlighted for new opportunities and specific market needs. Competitive Landscape and Technology Trends As the Genetic Testing Market grows, competition strengthens. This report profiles the leading players, analyzing their strategies, including mergers, acquisitions, and product innovations. Key players include: • Abbott • bioMerieux • Bio-Rad Laboratories • F. Hoffmann-La Roche • Myriad Genetics • QIAGEN • Quest Diagnostics The report also discusses technological advancements transforming the market, showing companies how they can harness innovation to stay competitive. Regulatory and Economic Insights The Genetic Testing Market is shaped by regulatory guidelines, and this report offers a detailed review of key regulations affecting the industry. It also explores economic factors like GDP growth, inflation, and employment trends, providing context for companies to develop strategies that respond to regulatory and economic changes. In summary, STATS N DATA's Global Genetic Testing Market Report delivers critical insights on market trends, competitive dynamics, and growth opportunities. Equipped with this information, companies and investors can make informed decisions to achieve success in a dynamic and competitive market. For customization requests, please visit: https://www.statsndata.org/request-customization.php?id=38369 John Jones Sales & Marketing Head | Stats N Data Phone: +1 (315) 642-4324 Email: sales@statsndata.org Website: www.statsndata.org STATS N DATA is a trusted provider of industry intelligence and market research, delivering actionable insights to businesses across diverse sectors. We specialize in helping organizations navigate complex markets with advanced analytics, detailed market segmentation, and strategic guidance. Our expertise spans industries including technology, healthcare, telecommunications, energy, food & beverages, and more. Committed to accuracy and innovation, we provide tailored reports that empower clients to make informed decisions, identify emerging opportunities, and achieve sustainable growth. Our team of skilled analysts leverages cutting-edge methodologies to ensure every report addresses the unique challenges of our clients. At STATS N DATA, we transform data into knowledge and insights into success. Partner with us to gain a competitive edge in today's fast-paced business environment. For more information, visit https://www.statsndata.org or contact us today at sales@statsndata.org This release was published on openPR.A political action committee affiliated with the Wyoming Freedom Caucus asked a Sweetwater County judge in October to dismiss a defamation case filed against the PAC this summer. Now, the plaintiffs — Rock Springs Republican Reps. J.T. Larson and Cody Wylie — are urging the court to deny the PAC’s motion to dismiss. “There is ample evidence that the WY Freedom PAC’s written communications were both false and defamatory,” the plaintiffs, represented by attorney and outgoing Rep. Clark Stith, R-Rock Springs, argued in their opposition filed Nov. 14. Larson and Wylie filed the original complaint in July after the PAC sent text messages and mailers to voters equating a vote on a 2024 budget amendment to the two lawmakers voting to remove President-elect Donald Trump from the ballot. Such a vote has never occurred in the Wyoming Legislature. In October, the two lawmakers filed an amended lawsuit to account for additional mailers the PAC sent after the initial complaint was filed and to try to strengthen their legal argument. Larson and Wylie, who were both reelected, stand by their belief the PAC knew its statements were false. Because the Legislature has never held a vote to remove Trump from the ballot, the complaint asserts the PAC made statements contrary to the truth with actual malice, a legal standard in defamation cases involving public figures. The suit also alleged the statements caused harm to the reputations of the plaintiffs and harmed one of their private businesses. The PAC, however, argued in its October motion to dismiss that the lawsuit fails to state a claim and the allegations do not constitute defamation. The PAC also said statements made to voters “were made in the course of political campaigning, where imaginative expressions and hyperbole are at their zenith.” The plaintiffs take issue with this stance, contending the PAC “essentially argues that political speech is different, that false statements are not really false if they are part of political discourse. “Although the standard of the defendant’s intent required (actual malice) is different for defamation of a public official than for a private individual (negligence), there is not a different measure of truth,” the plaintiffs wrote. “The court should reject Defendant’s attempt to create a ‘post-truth’ world of political discourse.” During the 2024 budget session, lawmakers clashed over which elected officials should have the authority to represent the state’s interest in litigation. That debate came after Secretary of State Chuck Gray joined Ohio’s and Missouri’s Republican secretaries of state in filing an amicus brief that advocated for overturning a Colorado court’s decision to remove Trump from that state’s ballot because of his role in inciting the Jan. 6, 2021 riots at the U.S. Capitol. The Joint Appropriations Committee responded by adding a footnote to the budget limiting the secretary of state’s ability to sue on Wyoming’s behalf. Some lawmakers argued on the House floor that the footnote was about separation of powers. More especially, the footnote ensured the state’s chief executive — the governor — remained the one office with the authority to speak on behalf of Wyoming in a courtroom. While some members of the Freedom Caucus argued the secretary of state’s office needed the ability to act quickly, others said the budget wasn’t the place for such a footnote. Ultimately, it was left out of the final budget bill passed by both chambers. Months later, the footnote became fodder for thousands of mailers targeting incumbent lawmakers, including Larson and Wylie but also others that lost their reelection bids, including Reps. Ember Oakley, R-Riverton, and Dan Zwonitzer, R-Cheyenne. The plaintiffs argue in their most recent filings that the timing of the mailers is telling. The PAC “admits that the Wyoming Secretary of State had already filed amicus briefs with both the Colorado Supreme Court and the United States Supreme Court in the case involving Trump’s right to appear on the Colorado ballot for president before plaintiffs cast their votes on a budget amendment that would first become effective on July 1, 2024,” the filing states. When the PAC asked the court to dismiss the complaint, it also made an alternative suggestion that the court resolve the case in its favor without a full trial — an order also known as summary judgment. But a summary judgment cannot be granted because the two parties do not agree on the material facts of the case, the plaintiffs argue. More specifically, the plaintiffs point to the PAC’s assertion that “a claim that one voted in favor of excluding Trump from the presidential ballot is not capable of defamatory meaning.” There is ample evidence, however, the plaintiffs contend. They also reiterate an argument from the amended complaint that support for the president-elect is so strong across the state “that whether one supports Trump has become a proxy for whether a person is a true Republican.” In the November election, Trump received 71.6% of the vote in Wyoming — stronger support than any other state. The PAC now has an opportunity to respond to the plaintiffs once more before the court weighs in. Earlier this month, the PAC requested an oral hearing for early 2025. Get any of our free email newsletters — news headlines, sports, arts & entertainment, state legislature, CFD news, and more.Stock Market: Sensex and Nifty, the domestic benchmark indices declined in early trade on Monday amid a steady outflow of foreign capital and weak trends in global markets. The 30-share BSE benchmark Sensex fell 142.26 points to 78,556.81. The NSE Nifty fell 48.35 points to 23,765.05. From the 30 blue chip pack, Power Grid, Infosys, HCL Technologies, Mahindra & Mahindra, Titan, Kotak Mahindra Bank, Tech Mahindra, and Tata Motors were the biggest laggards. Meanwhile, Adani Ports, Ultratech Cement, Zomato, and ITC are among the recipients. According to exchange data, foreign institutional investors offloaded equity worth Rs 1,323.29 crore on Friday. In Asian markets, Tokyo, Shanghai and Hong Kong traded less, while Seoul was more expensive. U.S. markets ended in negative territory on Friday. Also read: Vodafone Group Gives Nod To Raise About Rs 11,650 Crore Dues Against VIL Shares Brent crude, the global benchmark, rose 0.07 per cent to $74.22 a barrel. The benchmark BSE rose 226.59 points, or 0.29 per cent, to 78,699.07 on Friday. The Nifty rose 63.20 points, or 0.27 per cent, to 23,813.40. The US dollar fell 5 paise to 85.53 against the US dollar in early trade on Monday as dollar demand from importers, foreign capital outflows and a muted trend in domestic equities weighed on investor sentiment. In interbank forex, the rupee opened on a weaker note and fell to 85.53 against the US currency, registering a decline of 5 paise from the previous close. Also Read: Yearender 2024: How Digital Transformation Drives India's Growth In Infratech, Healthtech, Renewable Energy Sector?
AP News Summary at 11:51 a.m. EST
More than 10 million people empowered so far through the 34 by 34 initiative ATLANTA , Dec. 5, 2024 /PRNewswire/ -- Cox Enterprises today announced that it has empowered 10.6 million people to live more prosperous lives since 2020, a significant milestone in its 34 by 34 social impact initiative . This achievement represents a wide range of efforts across Cox and its businesses, Cox Communications and Cox Automotive. Cox is committed to solving business problems that also remove obstacles present in communities and society at large, from bridging the digital divide to addressing social equity and environmental sustainability challenges. "Cox is a company of innovators, changemakers and believers of being part of something bigger than ourselves," said Maury Wolfe , vice president of Corporate Responsibility and Social Impact at Cox Enterprises. "To drive our 34 by 34 social impact initiative forward, employees across our businesses have led countless acts of volunteering and community engagement, from cleaning up waterways and building outdoor learning labs to mentoring students. We're humbled to see the ripple effect throughout our communities." 34 by 34 focuses on six key pathways to create positive change: technology access, access to lifelong education, employment skills, social equity, environmental sustainability, and good health. These pathways provide a holistic approach to empowering individuals and communities. Key examples of Cox's business and employee volunteering impact include: Visit Cox34by34.com to see stories of our impact and watch this video to learn more about the 34 by 34 initiative. About Cox Enterprises Cox Enterprises is dedicated to empowering people to build a better future for the next generation. Cox is a leader in the broadband, automotive, and media industries, as well as a leading investment platform with strategic positions in emerging technologies driving the future of agriculture, renewable energy, healthtech, and public sector software. Headquartered in Atlanta, Georgia , Cox is a global company with $23 billion in annual revenues and a proud history spanning more than 125 years. To learn more about Cox and its commitment to its people, planet and communities, visit coxenterprises.com . View original content to download multimedia: https://www.prnewswire.com/news-releases/cox-enterprises-nearing-one-third-of-its-ambitious-goal-to-empower-34-million-people-to-live-more-prosperous-lives-by-2034-302324319.html SOURCE Cox EnterprisesBATESVILLE, Ind. , Dec. 5, 2024 /PRNewswire/ -- The board of directors of Hillenbrand, Inc. (NYSE: HI) has declared a regular quarterly cash dividend of $0.225 per share on the company's common stock. On an annualized basis, this is an increase of $0.01 per share to a total rate of $0.90 per share in fiscal 2025. The dividend is payable December 31, 2024 , to shareholders of record at the close of business on December 16, 2024 . About Hillenbrand Hillenbrand (NYSE: HI) is a global industrial company that provides highly-engineered, mission-critical processing equipment and solutions to customers in over 100 countries around the world. Our portfolio is composed of leading industrial brands that serve large, attractive end markets, including durable plastics, food, and recycling. Guided by our Purpose — Shape What Matters For TomorrowTM — we pursue excellence, collaboration, and innovation to consistently shape solutions that best serve our associates, customers, communities, and other stakeholders. To learn more, visit: www.Hillenbrand.com . View original content to download multimedia: https://www.prnewswire.com/news-releases/hillenbrand-declares-first-quarter-dividend-of-0-225-per-share-302324305.html SOURCE Hillenbrand
NEW YORK , Dec. 15, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of ASML Holding N.V. (NASDAQ: ASML) between January 24, 2024 and October 15, 2024 , both dates inclusive (the "Class Period"), of the important January 13, 2025 lead plaintiff deadline. So what: If you purchased ASML ordinary shares during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the ASML class action, go to https://rosenlegal.com/submit-form/?case_id=31159 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 13 , 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the issues being faced by suppliers, like ASML, in the semiconductor industry were much more severe than defendants had indicated to investors; (2) the pace of recovery of sales in the semiconductor industry was much slower than defendants had publicly acknowledged; (3) defendants had created the false impression that they possessed reliable information pertaining to customer demand and anticipated growth, while also downplaying risk from macroeconomic and industry fluctuations, as well as stronger regulations restricting the export of semiconductor technology, including the products that ASML sells; and (4) as a result, defendants' statements about ASML's business, operations, and prospects lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the ASML class action, go to https://rosenlegal.com/submit-form/?case_id=31159 mailto: or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ . Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com View original content to download multimedia: https://www.prnewswire.com/news-releases/asml-deadline-asml-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-asml-holding-nv-securities-fraud-lawsuit-302331928.html SOURCE THE ROSEN LAW FIRM, P. A.
Sea Eagles set to hand Seibold early Christmas present as fresh deal loomsNAIROBI, Kenya (AP) — What began as a childhood hobby more than six decades ago has led to what might be Africa's largest butterfly collection in a suburb of Kenya's capital. Steve Collins, 74, was born and raised in western Kenya. By the age of 5, he was fascinated by butterflies and started building a collection that has grown to more than 4.2 million, representing hundreds of species. “My parents encouraged us to look for butterflies after visiting the Congo and were gifted a trapping net by some friends," Collins said. “By the time I was 15 years old, I was already visiting other countries like Nigeria to study more about butterflies.” During his 20-year career as an agronomist, Collins dedicated his free time to research. He established the African Butterfly Research Institute in 1997. Now, running out of space and time, he hopes to hand it over to the next generation. On his 1.5 acres (0.6 hectare) of land, hundreds of indigenous trees and flowering bushes form a well-knit forest. Hundreds of butterflies dance from one flower to another, at times landing on Collins' hand. His collection is private, although it was initially open to the public when he ran it as an education center between 1998 and 2003. Collins has 1.2 million butterflies from across Africa delicately pinned in frames and stored in rows of shelves, with another 3 million in envelopes. “They need to be kept in dark spaces," he said. “The form of storage also ensures the dried butterflies are not eaten by other insects, parasites and predators. We also ensure we apply insecticides once a year to keep them safe.” Julian Bayliss, an ecologist specializing in Africa and a visiting professor at Oxford Brookes University, said he has collected butterflies for Collins over two decades. “There is a large part of that collection that is completely irreplaceable because a large part of Africa’s habitat is being destroyed,” Bayliss said. Africa is vulnerable to climate change, with periods of prolonged drought and serious flooding destroying forests and other butterfly habitats. Bayliss suggested digitizing the collection to make it accessible worldwide. Whoever takes it over "needs to be an institution that is well-founded, well-funded and secure,” he said. Scott Miller, an entomologist at the Smithsonian Institution, met Collins almost 30 years ago. He said such collections provide critical information that could show environmental changes over 60 years. “These physical specimens, you can actually keep going back to them to get new layers of information as you learn more or you get a different technology or you get different questions," he said. Collins is concerned that soon he will no longer be able to sustain his research. He said his most prized butterfly costs $8,000 — which he keeps from sight, concerned about possible theft — and hopes to sell the collection to an individual or research institution. The costs of running his institute are high. An annual budget posted in 2009 on the Lepidopterists' Society of Africa website was $200,000. Collins estimates that the specimens and other assets are worth $8 million. “This has been my hobby for decades, and I can’t put a price on what I have done so far. I’m currently seeking to ensure the species are in safe hands when I’m out of this world,” he said. Associated Press journalist Khaled Kazziha in Nairobi, Kenya, contributed to this report.
RYZ-101 is a synthetic peptide commercialized by , with a leading Phase III program in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET). According to Globaldata, it is involved in 4 clinical trials, of which 3 are ongoing, and 1 is planned. Smarter leaders trust GlobalData The gold standard of business intelligence. The revenue for RYZ-101 is expected to reach an annual total of $72 mn by 2038 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, otherwise known as net present value (NPV). Applying the drug’s phase transition success rate to remaining R&D costs and likelihood of approval (LoA) to sales related costs provides a risk-adjusted NPV model (rNPV). The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress. RYZ-101 Overview RYZ-101 is under development for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), extensive stage small cell lung cancer, relapsed and refractory multiple myeloma (MM). The drug candidate is an actinium-225 radiolabeled conjugated synthetic peptide somatostatin analog (SSA) which acts by targeting cell expressing somatostatin receptor 2 (SSTR2). It is administered parenterally and intravenously. Bristol-Myers Squibb Overview (BMS) is a specialty biopharmaceutical company. It is engaged in the discovery, development, licensing and manufacturing, marketing, distribution and sale of medicines and related medical products to patients with serious diseases. Its primary focus is on cancer, immunology, cardiovascular, and fibrotic diseases. The company offers its products across the world to wholesalers, retail pharmacies, medical professionals, hospitals and government entities. The company has an operational presence in the US, Switzerland, Puerto Rico, Ireland, and the Netherlands. The company conducts research to focus on the discovery and development of novel medicines that address diseases in areas of unmet medical need. BMS is headquartered in Princeton, New Jersey, the US. The company reported revenues of (US Dollars) US$45,006 million for the fiscal year ended December 2023 (FY2023), a decrease of 2.5% over FY2022. In FY2023, the company’s operating margin was 20.9%, compared to an operating margin of 20.9% in FY2022. In FY2023, the company recorded a net margin of 17.8%, compared to a net margin of 13.7% in FY2022. The company reported revenues of US$12,201 million for the second quarter ended June 2024, an increase of 2.8% over the previous quarter. For a complete picture of RYZ-101’s valuation, From Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors. , the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. To create this model, GlobalData takes into account factors including patent law, known and projected regulatory approval processes, cash flows, drug margins and company expenses. Combining these data points with GlobalData’s world class analysis creates high value models that companies can use to help in evaluation processes for each drug or company. The rNPV method integrates the probability of a drug reaching a clinical stage into the cash flow at that time, which provides a more accurate valuation, as it considers the probability that the drug never makes it through the clinical pathway to commercialization. GlobalData’s rNPV model uses proprietary likelihood of approval (LoA) and phase transition success rate (PTSR) data for the indication in the highest development stage, which can be found on GlobalData’s .
